Literature DB >> 25857761

Application of a Novel Brain Arteriovenous Malformation Endovascular Grading Scale for Transarterial Embolization.

D L Bell1, T M Leslie-Mazwi2, A J Yoo3, J D Rabinov4, W E Butler5, J E Bell6, J A Hirsch4.   

Abstract

BACKGROUND AND
PURPOSE: The advent of modern neuroendovascular techniques has highlighted the need for a simple, effective, and reliable brain arteriovenous malformation endovascular grading scale. A novel scale of this type has recently been described. It incorporates the number of feeding arteries, eloquence, and the presence of an arteriovenous fistula component. Our aim is to assess the validity of this grading scale.
MATERIALS AND METHODS: We retrospectively reviewed all suspected brain arteriovenous malformations at Massachusetts General Hospital from 2005 to 2013, identifying 126 patients who met the inclusion criteria. Spearman correlations between endovascular and Spetzler-Martin grading scales and long-term outcomes were performed. Median endovascular grades were compared between treatment modalities and endovascular outcomes. Binary regression analysis was performed with major endovascular complications as a dichotomized dependent variable. Intraclass correlation coefficients were calculated for interobserver reliability of the endovascular grading scale.
RESULTS: A significant Spearman correlation between the endovascular grade and the Spetzler-Martin grade was demonstrated (ρ = 0.5, P < .01). Differences in the median endovascular grades between the endovascular cure (median = 2) and endovascular complication groups (median = 4) (P < .05) and between the endovascular cure and successful multimodal treatment groups (median = 3) (P < .05) were demonstrated. The endovascular grade was the only independent predictor of complications (OR = 0.5, P < .01). The intraclass correlation coefficient of the endovascular grade was 0.71 (P < .01).
CONCLUSIONS: Validation of a brain arteriovenous malformation endovascular grading scale demonstrated that endovascular grades of ≤II were associated with endovascular cure, while endovascular grades of ≤III were associated with multimodal cure or significant lesion reduction and favorable outcome. The endovascular grade provides useful information to refine risk stratification for endovascular and multimodal treatment.
© 2015 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2015        PMID: 25857761      PMCID: PMC7965262          DOI: 10.3174/ajnr.A4286

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  30 in total

1.  Transarterial balloon assisted Onyx embolization of pericallosal arteriovenous malformations.

Authors:  Ludwig D Orozco; Gustavo D Luzardo; Razvan F Buciuc
Journal:  J Neurointerv Surg       Date:  2012-06-22       Impact factor: 5.836

2.  The pressure cooker technique for the treatment of brain AVMs.

Authors:  René Chapot; Paul Stracke; Aglaé Velasco; Hannes Nordmeyer; Markus Heddier; Michael Stauder; Petra Schooss; Pascal J Mosimann
Journal:  J Neuroradiol       Date:  2014-01-07       Impact factor: 3.447

3.  Commentary: unruptured brain arteriovenous malformations: what a tangled web they weave.

Authors:  Sepideh Amin-Hanjani; Felipe C Albuquerque; Gavin Britz; E Sander Connolly; Murat Gunel; Sean D Lavine; Michael T Lawton; Joel MacDonald; Christopher S Ogilvy; Charles J Prestigiacomo
Journal:  Neurosurgery       Date:  2014-08       Impact factor: 4.654

4.  Prognostic value of the Spetzler's grading system in a series of cerebral AVMs treated by a combined management.

Authors:  R Deruty; I Pelissou-Guyotat; C Mottolese; D Amat; Y Bascoulergue
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

5.  Complications of cerebral arteriovenous malformation embolization: multivariate analysis of predictive factors.

Authors:  Carlos J Ledezma; Brian L Hoh; Bob S Carter; Johnny C Pryor; Christopher M Putman; Christopher S Ogilvy
Journal:  Neurosurgery       Date:  2006-04       Impact factor: 4.654

Review 6.  A proposal for a new arteriovenous malformation grading scale for neuroendovascular procedures and literature review.

Authors:  Caleb E Feliciano; Ramón de León-Berra; Manuel S Hernández-Gaitán; Rafael Rodríguez-Mercado
Journal:  P R Health Sci J       Date:  2010-06       Impact factor: 0.705

7.  Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients.

Authors:  R Jahan; Y Murayama; Y P Gobin; G R Duckwiler; H V Vinters; F Viñuela
Journal:  Neurosurgery       Date:  2001-05       Impact factor: 4.654

8.  Transvenous embolization of a ruptured cerebral arteriovenous malformation with en-passage arterial supply: initial case report.

Authors:  Thanh N Nguyen; Lawrence S Chin; Rosemary Souza; Alexander M Norbash
Journal:  J Neurointerv Surg       Date:  2010-03-05       Impact factor: 5.836

9.  Treatment of brain arteriovenous malformations with high-flow arteriovenous fistulas: risk and complications associated with endovascular embolization in multimodality treatment. Clinical article.

Authors:  Ichiro Yuki; Robert H Kim; Gary Duckwiler; Reza Jahan; Satoshi Tateshima; Nestor Gonzalez; Alessandra Gorgulho; Jorge Lee Diaz; Antonio A De Salles; Fernando Viñuela
Journal:  J Neurosurg       Date:  2010-10       Impact factor: 5.115

10.  Treatment of brain arteriovenous malformations by embolization and radiosurgery.

Authors:  Y P Gobin; A Laurent; L Merienne; M Schlienger; A Aymard; E Houdart; A Casasco; D Lefkopoulos; B George; J J Merland
Journal:  J Neurosurg       Date:  1996-07       Impact factor: 5.115

View more
  2 in total

Review 1.  Modern radiosurgical and endovascular classification schemes for brain arteriovenous malformations.

Authors:  Ali Tayebi Meybodi; Michael T Lawton
Journal:  Neurosurg Rev       Date:  2018-05-04       Impact factor: 3.042

2.  Complications of Endovascular Treatments for Brain Arteriovenous Malformations: A Nationwide Surveillance.

Authors:  K Sato; Y Matsumoto; T Tominaga; T Satow; K Iihara; N Sakai
Journal:  AJNR Am J Neuroradiol       Date:  2020-03-19       Impact factor: 3.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.